Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
International Journal of Molecular Sciences
|
October 13, 2021
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways
Ralf Kircheis
International Journal of Molecular Sciences
|
May 25, 2024
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants
Ralf Kircheis
International Journal of Molecular Sciences
|
June 26, 2026
In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2
Ralf Kircheis
International Journal of Molecular Sciences
|
September 14, 2024
Special Issue "The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0"
Ralf Kircheis, Oliver Planz
International Journal of Molecular Sciences
|
April 13, 2023
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation
Ralf Kircheis, Oliver Planz
Cancer Biology & Therapy
|
May 24, 2005
EpCAM is not a LAIR-1 ligand!
Andreas Nechansky, Ralf Kircheis
Expert Opinion on Drug Discovery
|
July 26, 2012
Immunogenicity of therapeutics: a matter of efficacy and safety
Andreas Nechansky, Ralf Kircheis
International Journal of Molecular Sciences
|
June 10, 2022
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?
Ralf Kircheis, Oliver Planz
Frontiers in Immunology
|
February 5, 2024
Editorial: The role of toll-like receptors and their related signaling pathways in viral infection and inflammation
Oliver Planz, Ralf Kircheis
Current Opinion in Molecular Therapeutics
|
September 30, 2003
Technology evaluation: TNFerade, GenVec
Ralf Kircheis, Ernst Wagner
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
International Journal of Molecular Sciences
|
October 13, 2021
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways
Ralf Kircheis
International Journal of Molecular Sciences
|
May 25, 2024
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants
Ralf Kircheis
International Journal of Molecular Sciences
|
June 26, 2026
In Silico Modeling of Structural Compatibility and Alignment Between Viral Class I Fusion Cores and Human TLR4/MD-2
Ralf Kircheis
International Journal of Molecular Sciences
|
September 14, 2024
Special Issue "The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0"
Ralf Kircheis, Oliver Planz
International Journal of Molecular Sciences
|
April 13, 2023
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation
Ralf Kircheis, Oliver Planz
Cancer Biology & Therapy
|
May 24, 2005
EpCAM is not a LAIR-1 ligand!
Andreas Nechansky, Ralf Kircheis
Expert Opinion on Drug Discovery
|
July 26, 2012
Immunogenicity of therapeutics: a matter of efficacy and safety
Andreas Nechansky, Ralf Kircheis
International Journal of Molecular Sciences
|
June 10, 2022
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?
Ralf Kircheis, Oliver Planz
Frontiers in Immunology
|
February 5, 2024
Editorial: The role of toll-like receptors and their related signaling pathways in viral infection and inflammation
Oliver Planz, Ralf Kircheis
Current Opinion in Molecular Therapeutics
|
September 30, 2003
Technology evaluation: TNFerade, GenVec
Ralf Kircheis, Ernst Wagner
Page
of 4